CompletedNot Applicable

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

United States168 participantsStarted 2019-09-05

Plain-language summary

This is a prospective study to establish the analytical specificity of Bladder EpiCheck test in urine samples from healthy population and urology patients without prior history or evidence of bladder cancer.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Benign non-genitourinary disease (e.g. heart disease)
✓. Non-genitourinary cancers (e.g. lung, CRC, breast)
✓. Genitourinary disease other than bladder cancer including:
✓. Benign prostatic hyperplasia (BPH)
✓. Microhematuria proven negative for bladder cancer through prior UCC evaluation
✓. Inflammation/infection
✓. Symptomatic sexually transmitted disease (STD)
✓. Urinary tract stones

What they're measuring

Specificity

Timeframe: Day 1

Trial details

NCT IDNCT06020807

SponsorNucleix Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-01-08

View on ClinicalTrials.gov More Non Muscle Invasive Bladder Cancer trials